Selected article for: "safety efficacy and vaccine development"

Author: Zahoor, Bilal A.; Mudie, Lucy I.
Title: The imperative to develop a human vaccine for the Hendra virus in Australia
  • Document date: 2015_10_29
  • ID: wu77xf6c_7
    Snippet: Proficiency in managing an emerging outbreak should not be acknowledged by way of unfortunate experience if the outbreak can be prevented first-hand. Guidelines for human vaccine development encompass principles of cost, efficacy, and safety (8) . Guidelines of animal vaccine development are less stringent (2, 6) . The development of a human HeV vaccine can be time-consuming and prohibitively costly at the current stage. This strategy, however, i.....
    Document: Proficiency in managing an emerging outbreak should not be acknowledged by way of unfortunate experience if the outbreak can be prevented first-hand. Guidelines for human vaccine development encompass principles of cost, efficacy, and safety (8) . Guidelines of animal vaccine development are less stringent (2, 6) . The development of a human HeV vaccine can be time-consuming and prohibitively costly at the current stage. This strategy, however, is much more feasible than the one concerning the containment of an emerging infection Á clearly evidenced after taking into account the responses to the recent emergence of bat-related zoonotic epidemics such as Ebola and MERS-CoV.

    Search related documents:
    Co phrase search for related documents
    • hand prevent and safety efficacy: 1
    • hev vaccine and human hev vaccine: 1, 2, 3, 4, 5
    • hev vaccine and human hev vaccine development: 1, 2, 3
    • hev vaccine and human vaccine: 1, 2, 3, 4, 5, 6
    • hev vaccine and recent emergence: 1
    • hev vaccine and safety efficacy: 1
    • hev vaccine and zoonotic epidemic: 1, 2
    • human hev vaccine and zoonotic epidemic: 1, 2
    • human hev vaccine development and zoonotic epidemic: 1
    • human vaccine and recent emergence: 1
    • human vaccine and safety efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
    • human vaccine and safety efficacy cost: 1
    • human vaccine and zoonotic epidemic: 1, 2
    • recent emergence and safety efficacy: 1, 2
    • recent emergence and zoonotic epidemic: 1
    • safety efficacy and zoonotic epidemic: 1